SMO and pancreatic neoplasm: Onishi and colleagues confirmed, using triple staining fluorescence immunohistochemistry of surgically-resected pancreatic cancer tissues, that GLI1 and SMO proteins are partially co-expressed with CAIX, a marker of hypoxia [85].